期刊文献+

大肠癌虚证实证与CD44v6、PCNA表达的相关性研究 被引量:11

The Study on Expression of CD44V6、PCNA in Different Patterns of Colorectal Cancer in TCM Syndrome Differentiation
下载PDF
导出
摘要 目的:通过检测细胞粘附分子(CD44v6)及增殖细胞核抗原(PCNA)在大肠癌不同中医证型中的表达,探讨CD44v6、PCNA与虚实证型的关系。方法:采用前瞻性组间对照的研究方法,筛选符合标准的大肠癌患者51例和大肠息肉患者17例,术前认真辨证,术后标本免疫组化检测各种证型组织中CD44v6及PCNA的表达。结果:息肉组织中CD44v6无表达或呈弱表达,大肠癌组织中CD44v6表达明显增强。大肠癌虚证与实证中有淋巴结转移或全身多处转移的患者,CD44v6的表达有显著差异性(P<0.05),实证占85.7%,虚证占46.2%,而PCNA的表达无差异性(P>0.05)。结论:CD44v6、PCNA在大肠癌中的表达具有较高的特异性。CD44v6作为细胞黏附蛋白分子,同肠癌的发生与发展可能有关,对大肠癌预后的判断具有重要的参考价值。PCNA在大肠癌进展期表达具有特征性意义。大肠癌实证中有淋巴结转移或全身多处转移的患者CD44v6的表达明显高于虚证中的表达,提示CD44v6及转移倾向与邪气的盛衰相关。 dObjective To explore the significance of CD44V6 and PCNA, and to reveal the essence as well as the gene relationship by detecting the expression of CD44V6 and PCNA in different patterns of colonrec- tal cancer on TCM syndrome differentiation. Method A prospective controlled study method was introduced. Fifty one colonrectal cancer patients and 17 patients with colonrectal polypus were divided into two groups rela- tively.The dialectical information was recorded preoperatively and all the colonrectal cancer patients had been pa- thology examinated postoperatively, CD44V6 and PCNA were immunohistoehemically detected. Result CD44v6 was highly expressed in colorectal carcinoma, while in colonreetal polypus, the expression was not obvi- ous, with significant differences(P〈0.05).The PCNA was highly expressed in both eolorectal carcinoma and poly- pus, the distribution was heterogeneous. The expression of CD44v6 in colonrectal cancer with positive lymph node and multiple metastasis was significantly different between excessive and deficient patterns(P〈0.05), the expression rate in excessive patterns was 85.7%,while in deficient patterns 46.2%, and the expression of PC-NA had no distinguish between thetwo groups.Conclusion The expression of CD44v6 and PCNA in colorectal carcinoma has a high specificity. CD44v6 may have correlation with the occurrenceand development of colorectal cancer, well as the prognosis. The expression of PCNA in colorectal carcinomaprogression has a characteristic.The expression of CD44v6 in colonrectal cancer excessive patterns with positivelymph nodes and multiple metastasis is significantly higher than there in the deficiency patterns, which reflectsdeficiency-excess theory of TCM. CD44v6 is also related to transfer orientation and up and down of pathogenicqi in TCM syndrome diagnosis.
出处 《中国中西医结合外科杂志》 CAS 2012年第3期234-237,共4页 Chinese Journal of Surgery of Integrated Traditional and Western Medicine
基金 2010年中山市科学技术局立项并资金资助项目(20102A095)
关键词 大肠癌 CD44V6 PCNA 中医证型 免疫组织化学 Colorectal cancer, CD44v6 PCNA TCM syndrome type Immunohistochemistry
  • 相关文献

参考文献6

  • 1吴孟超;吴在德.黄家驷外科学[M]北京:人民卫生出版社,2008(1):1640-1641.
  • 2Wheatley SC,Isacke CM,Crossley PH. Restricted expression of the hyaluronan receptor,CD44,during postimplantation mouse embryogen-esis suggests keyroles in tissue formation and patterning[J].Development,1993,(02):295-306.
  • 3Sleeman J,Moll J,ShermanL. The role of CD44 splice variants in human metastatic cancer:Cell adhesion and human disease[A].Wiley Press,1995.142-156.
  • 4Yamane N,Tsujitani S,Makino M. Soluble CD44 variant as a prognostic indicator in patients with colorectal cancer[J].Oncology(Basel),1999,(03):232-238.
  • 5岳辉,张宁,冯新莉,麻树人,宋福林,杨明,唐谊海.胰腺癌组织中p57^(kip2)、cyclin E和PCNA表达与临床病理因素的关系[J].癌症,2003,22(7):705-709. 被引量:11
  • 6成克伦,罗泊涛,杨宇明,李德祥.甲状腺肿瘤细胞PCNA和Ki-67抗原表达及其相关性研究[J].中国医师杂志,2004,6(2):193-195. 被引量:2

二级参考文献29

  • 1贾学玲,高云荷,张煦.子宫内膜增生及内膜癌中PTEN、Ki-67蛋白的表达[J].临床与实验病理学杂志,2003,19(2):152-155. 被引量:19
  • 2Sherr CJ. Cancer cell cycles[J]. Science, 1996, 274: 1672-1677.
  • 3Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinase(CDKs), growth suppressor and cyclin dependent kinase inhibitors(CDKIs) [J]. J Oncogene,1995, 11:211 -219.
  • 4Kamb A. Cell-cycle regulators and cancer[J]. J Trends Genet,1995, 11: 136- 140.
  • 5Ciaparrone M, Yamamoto H, Yao Y, et al. Localization and expression of p27^kipl in multistage colorectal carcinogenesis[J].Cancer Res, 1998, 58:114 - 122.
  • 6Hunter T, Pines J. Cyelins and cancer Ⅱ: Cyclins and CDK inhibitors come of age[J]. Cell, 1994,79:573 -576.
  • 7Clurman BE, Roberts JM. Cell cycle and cancer[J]. J National Cancer Institute, 1995, 87:1499 - 1504.
  • 8Matsuoka S, Edwards MC, Bai C, et al. p57^juo2 a structurally distinct member is a candidate tumor suppressor gene[J]. Genes Dev, 1995, 9:650 - 662.
  • 9Orlow 1, lavarone A, Crider-Miller SJ, et al. Cyclin-dependent kinase inhibitor p57^kip2 in soft tissue sarcoma and Wilms tumor[J].Cancer Res, 1996, 56:1219 - 1221.
  • 10Lee MH, Reynisdottir I, Massague J. Cloning of p57^kip2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distrlbution[J]. Genes Dev, 1995, 9:639-649.

共引文献11

同被引文献153

引证文献11

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部